版本:
中国

BRIEF-Oncolytics Biotech enters collaboration with Myeloma UK and Celgene

March 16 Oncolytics Biotech Inc

* Oncolytics biotech enters into first-in-class collaboration with Myeloma UK and Celgene using Reolysin in combination with Imnovid or Revlimid in patients with Myeloma

* Phase 1b trial will study immuno-viral therapy, Reolysin in combination with Celgene Corporation's immunomodulatory drugs Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐